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Complex regional pain syndrome (CRPS) is a neuropathic pain condition that is characterized by vasomotor, sensory, sudomotor,
and motor symptoms. Spinal cord stimulation (SCS) has been successfully utilized for the treatment of pain refractory to
conventional therapies. We present a case of a previously highly functioning 54-year-old female who developed a rarely reported
case of idiopathic CRPS of the right ankle which spontaneously occurred four months after an uncomplicated anterior cervical disc
fusion. This condition resulted in severe pain and functional impairment that was unresponsive to pharmacological management.
The patient’s rehabilitation was severely stymied by her excruciating pain. However, with the initiation of spinal cord stimulation, her
pain was adequately controlled allowing for progression to full unassisted ambulation, advancing functional capacity, and improving
quality of life. This case report supports the concept that rapid progression to neuromodulation, rather than delays that occur due
to attempts at serial sympathetic blocks, may better control symptoms leading allowing for a more meaningful recovery.

1. Introduction
Complex regional pain syndrome (CRPS) is a neuropathic
pain condition characterized by sensory, vasomotor, sudomotor, and motor/trophic signs and symptoms [1]. CRPS type
2 formerly known as causalgia is preceded by a major nerve
injury. CRPS type 1 formerly known as reflex sympathetic
dystrophy presents with similar symptoms as type 2 with the
absence of a major nerve injury. It usually is preceded by some
trauma to the limb [2]. Although the pathophysiology of this
condition is not well understood, it is often preceded by a
trauma or an operation on an extremity [3]. The incidence of
CRPS has been reported as 5.46 cases per 100,000 persons,
with increased frequency in women [4, 5]. CRPS resolves
within the first year after diagnosis in 70–85% of patients,

but in the remaining 15–20% becomes refractory to treatment
[4]. Currently there are no criteria for identifying those
patients who will progress to the chronic form of CRPS,
although sensory disturbance and cold skin temperature
are associated with poor prognosis [6]. In patients who
have CRPS chronically, the condition can be considerably
debilitating. Extreme pain, low functionality, and permanent
disability significantly affect not only the quality of life for
those with CRPS, but also the lives of the families [7, 8].
Overall, treatment of CRPS has produced mixed results,
with no scientifically validated treatment. Some of the
treatment modalities that have been used to treat CRPS
include physical therapy, occupational therapy, conventional
pain medications, antidepressants, anticonvulsants, opioids,
ketamine infusions, sympathetic blocks, transcutaneous
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electrical stimulation, and spinal cord stimulators [9, 10].
Spinal cord stimulators (SCS) are often tried only after other
treatment modalities have failed to produce positive results.
Used for the treatment of chronic pain since 1967, spinal
cord stimulators have proven effectiveness in treatment of
the burning pain associated with CRPS, but less evidence for
improvement in limb functionality, and reduction in allodynia and hyperesthesia [11, 12]. When using a SCS, an electrode
is percutaneously or surgically placed into the epidural space
on the dorsal side of the spinal cord corresponding to the
level of the nerve roots supplying innervations to the area
with pain. The current supplied by the electrodes induces
paresthesias and suppresses pain sensation in the affected
limbs, although production of paresthesias over the affected
body part is not required for pain relief and functional
improvement [1, 13].
Implanting a SCS is often considered both an expensive
and an invasive treatment, and satisfactory lead placement is
necessary for successful treatment. On the other hand, despite
the apparent upfront cost, if the treatment is appropriate and
is shown to have good outcomes, overall costs, morbidity,
and chronic decreased functionality would be significantly
reduced with fewer ineffective treatments and tests. Studies
in both the US and in the United Kingdom comparing the
use of SCS with conventional management alone determined
that, in selected patients with CRPS, SCS is cost-effective
[2, 14]. We present a case of a woman with CRPS type
1 refractory to conservative efforts, who was treated with
early spinal cord stimulation, foregoing the traditional, and
recommended time line of interventions and found to have
improved ambulation and functionality of the affected limb
immediately and over the next six months.

2. Case Presentation
The patient is a 54-year-old, outdoors-oriented woman who
began to experience intermittent pain, paresthesias, and
numbness of the right arm followed by the same symptoms in
the bilateral lower extremities. Within 4–6 weeks she was only
able to walk with assistance and then limited to a wheelchair.
The patient had an MRI of her brain and spinal cord to rule
out multiple sclerosis (MS). Her brain MRI revealed some
white matter lesions that were not consistent with MS, but
her C-spine MRI showed a significant C5-6 herniated nucleus
pulposus and severe canal stenosis at C5-6, which flattened
her spinal cord. This pathology was thought to be the cause
of her symptoms. Subsequently, she underwent a C4–C7
anterior cervical discectomy and fusion surgery. The surgery
appeared successful as she was ambulating independently
within 1 week of surgery and hiking long distances at altitude
within 6 weeks. At this point, the patient did not have any
physical limitations or deficits. Four months after surgery,
she began to experience unexplained pain, paresthesias, and
numbness in her right foot/ankle. This quickly became an
uncontrollable pain requiring axillary crutches and then a
wheelchair. After three months of the foot/ankle pain, she
was seen by Physical Medicine and Rehabilitation and was
then enrolled in a comprehensive rehabilitation program
for presumed CRPS. Even though she was treated with
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opioid and neuropathic pain medications (morphine sulfate,
gabapentin, pregabalin, and amitriptyline), she was unable
to participate fully in physical therapy due to pain. During
month 4 of foot/ankle symptoms, the pain worsened and
she was no longer able to bear weight on her right lower
extremity and the foot/ankle began to exhibit classic signs and
symptoms of CRPS including allodynia, edema, erythema,
hyperhidrosis, decreased range of motion, and dystonia [15,
16]. Electrodiagnostic studies showed no evidence of large
fiber neuropathy, distal tibial neuropathy, or right lower lumbosacral radiculopathy. However, testing revealed significant
asymmetry in skin temperature, 29.0 Celsius on the left lower
extremity and 26.3 Celsius on the right, along with asymmetrically prolonged onset latency difference of 484 msec
on the right. She was expedited to the Department of Pain
Management for sympathetic blocks, but it was decided to
pursue early neuromodulation instead. Approximately 4-5
months after the onset of symptoms she underwent successful
SCS trial. The trial was performed in the pain management
clinic and consisted of the placement of one percutaneous
lead with eight electrodes introduced via a 14 gauge modified
Tuohy needle and entering the epidural space in a parasagital
approach at L2-3 under fluoroscopy. Lead location in the
posterior epidural space was confirmed with lateral fluoroscopy. The trial lead was advanced carefully to the T11-12
disc space under intermittent fluoroscopy (Figures 1 and 2).
The patient reported incredible pain relief and that she was
ambulating around her home for the first time in months. The
paresthesias over her most painful areas allowed her to regain
the majority of previously lost function and she began to take
fewer medications. Because of the unqualified success of the
trial, she went on to successful implantation in the operating
room of two percutaneous leads with eight electrodes placed
in the same area as the trial. For the implantation, two leads
were used instead of one in order to maximize potential
programming ability (Figures 3 and 4). She reported that
the induced paresthesias allowed her to stand and ambulate
around her home for the first time in months and to begin
actively participating in intensive physical and occupational
therapy. After placement of the SCS, the patient was seen
for physical and occupational therapy sessions of one hour
each, five times per week, for four weeks. Sessions were
then decreased to one hour each, three times per week,
for fourteen weeks. Physical therapy consisted of graduated
weight-bearing, gait training, stepping and balance drills,
recumbent cycling, standing elliptical, and lower extremity
strengthening exercises. Occupational therapy consisted of
desensitization, treatment with IFC (inferential current), and
graded motor imagery. The patient was seen regularly by a
Physical Medicine and Rehabilitation physician to monitor
symptoms and adjust medication and functional therapy as
needed. She was also seen regularly in the Department of
Pain Management for follow-up of the SCS and an IFC unit
was prescribed for home use as well. In addition, the patient
was seen weekly by a behavioral health psychologist (also
within the Department of Pain Management) for cognitive
behavioral therapy and biofeedback. Finally, the patient
participated in an 8-week course of mindfulness-based stress
reduction. Ten months after the onset of symptoms she is no
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Figure 1: AP fluoroscopic view of SC trial placement.

Figure 3: AP fluoroscopic view of SCS implantation.

Figure 2: Lateral fluoroscopic view of SCS trial.

Figure 4: Lateral fluoroscopic view of SCS implantation.

longer taking pain medication, is independent in all ADLs,
and has returned to work.

3. Discussion
The treatment of CRPS requires prompt diagnosis and timely
referral to avoid secondary morbidity related to disuse of the
affected limb and to reduce the risk of developing a refractory,
chronic form of the disorder [17]. Current recommendations
for initial treatment of CRPS include integrated multidisciplinary management, pain control with oral medications
such as anticonvulsants, tricyclic antidepressants, or opioids,
physical and occupational therapy, and psychological support
including cognitive behavioral therapy [12, 16–18]. More invasive interventions are generally reserved for refractory cases.
Recently in the literature there has been some discussion
about using spinal cord stimulation earlier in the treatment
of CRPS [2] Poree et al. state that in some cases, SCS for the
treatment of chronic pain of CRPS is “safe, appropriate, more
cost effective with a relatively low time to fiscal neutrality,

and as effective or even more effective when compared with
chronic opioid maintenance or conservative management.”
This particular patient had early mobilization and treatment with opioids and anticonvulsants. After these measures
failed, she was sent to the Department of Pain Management for consideration of a sympathetic nerve block. However, evidence-based reviews suggest that sympathetic nerve
blocks are not effective in reducing CRPS pain or at best have
only transient effects [19]. In addition, it was felt that time
spent pursuing ineffective treatment could delay adequate
mobilization and allow the disorder to progress to a chronic
state. It was decided to proceed directly to a SCS trial. The
pain control then provided by successful implantation of a
SCS was sufficient for the patient to begin actively engaging
in mobilization and desensitization therapies. While it is
likely that the comprehensive treatments she received after
SCS implant were key to restoration of function, adequate
pain control was the initial priority and the catalyst which
facilitated rehabilitation.
Although this is a single case report, further review of
the literature and/or small clinical trials should be considered
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to see how effective early treatment with neuromodulation
therapy can be for CRPS I patients. This endeavor would be
worthwhile because the goal of treatment is to get patients
back to normal functioning as quickly as possible.
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